HTR3E IDG ionchannel ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with HTR3E IDG ionchannel ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with HTR3E IDG ionchannel ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with HTR3E IDG ionchannel ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with HTR3E IDG ionchannel ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

deleted in lymphocytic leukemia 1

Gene

tumor suppressing subtransferable candidate 2 (pseudogene)

Gene

CD99 molecule pseudogene 1

Gene

CD99 molecule pseudogene 1

Gene

BMS1 pseudogene 1

Gene

mediator complex subunit 15 pseudogene 9

Gene

GCSH pseudogene 5

Gene

ovostatin 2, pseudogene

Gene

transmembrane protein 238 like

Gene

ribosomal protein S4X pseudogene 22

  • Gene

    deleted in lymphocytic leukemia 1


  • Gene

    tumor suppressing subtransferable candidate 2 (pseudogene)


  • Gene

    CD99 molecule pseudogene 1


  • Gene

    CD99 molecule pseudogene 1


  • Gene

    BMS1 pseudogene 1


  • Gene

    mediator complex subunit 15 pseudogene 9


  • Gene

    GCSH pseudogene 5


  • Gene

    ovostatin 2, pseudogene


  • Gene

    transmembrane protein 238 like


  • Gene

    ribosomal protein S4X pseudogene 22

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.